Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 12/20 | 0.33 |
| ▸ | SYK | P43405 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.30 |
| ▸ | SOS2 | Q07890 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6772670 | 1.00 | F10 (0.33) | F10SYKF2NR4A2SOS2 | |
| SCHEMBL4388434 | 0.90 | F10 (0.32) | F10SYK | |
| SCHEMBL4397516 | 0.89 | F10 (0.44) | F10F2 | |
| SCHEMBL4397517 | 0.89 | F10 (0.44) | F10F2 | |
| SCHEMBL27539622 | 0.89 | F10 (0.44) | F10F2 | |
| SCHEMBL1652219 | 0.88 | F10 (0.35) | F10NR4A2SOS2 | |
| SCHEMBL4385646 | 0.88 | F10 (0.35) | F10NR4A2SOS2 | |
| SCHEMBL4393690 | 0.88 | F10 (0.35) | F10NR4A2SOS2 | |
| SCHEMBL4393695 | 0.88 | F10 (0.35) | F10NR4A2SOS2 | |
| SCHEMBL4394129 | 0.88 | F10 (0.32) | F10SYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040102450-A1 | Substituted oxoazaheterocyclyl compounds | AVENTIS PHARMACEUTICALS INC. (US) | 2004-05-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102450-A1 | Substituted oxoazaheterocyclyl compounds | F13B, F9, F11 | F10 12/4885SYK 3299/4885F2 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.